Healthcare Sales & Marketing Network News: BiondVax Pharmaceuticals

Searching News Database: BiondVax Pharmaceuticals

HSMN NewsFeed - 21 Jan 2021
BiondVax Announces Appointment of Amir Reichman as New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2020
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2019
Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial
Biopharmaceuticals

HSMN NewsFeed - 14 Aug 2018
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Dec 2017
BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Jan 2017
BiondVax Receives $US 2.8 Million Investment From Angels High Tech Investments Ltd.
Biopharmaceuticals Venture Capital

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.